A hidden “jack-in-the-box” mechanism inside T cells may hold the key to unlocking more powerful cancer immunotherapies.

BioRender helps scientists draw biological diagrams more easily and communicate more efficiently. It's used by half a million ...

Insilico Medicine (3696.HK), a clinical-stage drug discovery and development company driven by generative artificial intelligence (AI), is successfully listed on the Hong Kong Stock Exchange today, ...

Studying one of the simplest animals, Stanford's Prakash Lab uncovered how it folds itself into complex shapes—revealing new ...

Immunovant (NASDAQ:IMVT) advances autoimmune research as nasdaq today reflects activity across clinical-stage biotech ...

One of the most exciting advances in cancer treatments in the past decade is the development of T cell immunotherapies, in which a patient's own immune system is trained to recognize and attack ...

A controversy is swirling at a Texas university. The trigger? A flowchart. On Dec. 1, the new chancellor of the Texas Tech University system sent professors a diagram laying out a chain of approval ...

Overcoming acquired treatment resistance is one of the major challenges in the fight against cancer. While combination ...

Bloodstream infections (BSIs) remain a critical challenge in clinical care, where every hour of delay in diagnosis can ...

PDAOAI PDAOAI Platform and Opens Access to Its Total TGF-β Knowledge Corpus AGOURA HILLS, Calif., Dec. 22, 2025 (GLOBE ...

When you take a drug, where in your body does it actually go? For most medications, scientists can make only educated guesses ...